VTE Diagnosis & Exclusion Pathway

Sequential Wells, PERC & YEARS Synthesis Engine · v1.8
How to use this tool: Enter the clinical findings in the order asked. The tool holds the sequence: clinical probability, then the PERC rule, then age-adjusted or YEARS-adjusted D-dimer, so venous thromboembolism is excluded with the least imaging and cost.

1. Target Pathology

2. Demographics & Vitals

3. Clinical Vitals

4. Clinical History

5. Presenting Symptoms & Gestalt

Academic Pearls & Pathophysiology

1. Clinical Context: Avoiding Financial & Renal Toxicity

[CLINICAL CAUTION] The Defensive Reflex: In crowded Indian EDs and OPDs, D-Dimer and CTPA are frequently ordered as a defensive reflex for any patient with chest pain or dyspnoea. This leads to massive out-of-pocket financial burden and unnecessary exposure to radiation and contrast-induced nephropathy. The PERC rule exists to halt this cascade. If a patient is low risk and PERC negative, a D-dimer is clinically contraindicated.

2. Mnemonic: PERC Rule-Out Criteria

Use the HAD CLOTS mnemonic to remember the 8 variables that must be absent to rule out PE without a D-dimer:

Hormone use (Oestrogen)
Age ≥ 50
DVT or PE history

Coughing blood (Haemoptysis)
Leg swelling (Unilateral)
O₂ Saturation < 95%
Tachycardia (HR ≥ 100)
Surgery or Trauma (Recent)

3. Pathophysiology: Age-Adjusted D-Dimer

The "Why": D-Dimer is a degradation product of cross-linked fibrin. As humans age, baseline coagulation activation and low-grade systemic inflammation naturally increase, causing healthy older adults to have elevated baseline D-dimer levels. Using a strict 500 ng/mL cut-off in a 75-year-old leads to massive false positives. Age-adjustment (Age × 10) restores the specificity of the test without sacrificing safety.

4. Illness Scripts: Chest Pain / Dyspnoea

Pulmonary Embolism (PE)
Presentation: Sudden onset pleuritic chest pain, unexplained tachycardia out of proportion to fever, clear lungs on auscultation, hypoxaemia.
Discriminator: Presence of unilateral leg swelling or recent immobilisation.
Acute Coronary Syndrome (ACS)
Presentation: Crushing, retrosternal pressure radiating to jaw/arm, diaphoresis, nausea.
Discriminator: Pain is usually non-pleuritic. ECG changes (ST elevation/depression).
Lobar Pneumonia
Presentation: Gradual onset, productive cough, high-grade fever with chills.
Discriminator: Focal crackles/bronchial breath sounds on auscultation. Elevated procalcitonin.
Abbreviations: ACS (Acute Coronary Syndrome) · CT (Computed Tomography) · CTPA (Computed Tomography Pulmonary Angiography) · DDU (D-Dimer Units) · DVT (Deep Vein Thrombosis) · ECG (Electrocardiogram) · ED (Emergency Department) · FEU (Fibrinogen Equivalent Units) · HR (Heart Rate) · HRT (Hormone Replacement Therapy) · LMWH (Low Molecular Weight Heparin) · O₂ (Oxygen) · OCP (Oral Contraceptive Pill) · OPD (Outpatient Department) · PE (Pulmonary Embolism) · PERC (Pulmonary Embolism Rule-out Criteria) · SaO₂ (Arterial Oxygen Saturation) · VTE (Venous Thromboembolism)
Algorithm References & Evidence Base
  1. Wells PS, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging. Ann Intern Med. 2001;135(2):98-107.
  2. Kline JA, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008;6(5):772-780.
  3. van der Hulle T, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study). Lancet. 2017;390(10091):289-297.
  4. Giri J, Bhatt DL, Barnes GD, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults. Circulation / J Am Coll Cardiol. 2026. Published 20 February 2026. [First joint US guideline dedicated to acute PE. Introduces the AHA/ACC Acute Pulmonary Embolism Clinical Categories for severity classification. The Wells, PERC and YEARS instruments computed here remain in use for exclusion; the new categories govern what happens after PE is confirmed.]
  5. Indian College of Cardiology / Association of Physicians of India (API). National Consensus on Management of Venous Thromboembolism. J Assoc Physicians India. 2018.
How to Cite This Tool

AMA Style:
Umakanth S. VTE Diagnosis & Exclusion Pathway. MEDiscuss. Published 2026. Accessed .

Vancouver Style:
Umakanth S. VTE Diagnosis & Exclusion Pathway [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:

Disclaimer and scope
Disclaimer: This decision-support system is intended for healthcare professionals. It does not substitute clinical judgment. These algorithms are evidence-based, but medical knowledge evolves continuously. The treating physician retains absolute responsibility for all diagnostic, dosing, and therapeutic decisions. Always verify outputs against current institutional protocols and individual patient contexts.
© 2026 MEDiscuss.org. All rights reserved. This CDSS Module was designed and developed by Dr. Shashikiran Umakanth using the available evidence base. Provided free of charge for clinical use. Unauthorised reproduction or redistribution is strictly prohibited.
Category Risk Scores & Diagnostic PathwaysPathway
Specialties Internal Medicine, Cardiology
Written and maintained by Dr Shashikiran Umakanth.
Last revised: 8 August 2026
Related Clinical Tools
Pregnancy VTE ExclusionVKA / Warfarin TitrationPre-Surgical Risk Pathway
Back to All Medical Calculators & Pathways